Exchange: NASDAQ·Updated 04:00 AM EDT
NNNN logo

NNNN Anbio Biotechnology

$6.60
$0.00
(0.00%)
Pre-Market
Prev Close $6.60
Mkt Cap$949.68M
Vol6.00

About NNNN

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
44

Bearish Sentiment

How do you feel about NNNN?

Advertisement|Remove ads.